MCM3AP and type 2 diabetes mellitus: Plasma MCM3AP-AS1 level was significantly lower in DR and T2DM groups than in the Control group (Fig. 1A, p < 0.05) and significantly lower in DR patients than in T2DM patients (Fig. 1A, p < 0.05).